Antisense-mediated suppression of Heparanase gene inhibits melanoma cell invasion

被引:66
作者
Roy, M
Reiland, J
Murry, BP
Chouljenko, V
Kousoulas, KG
Marchetti, D
机构
[1] Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA
[2] Louisiana State Univ, Sch Vet Med, Div Biotechnol & Mol Med, Baton Rouge, LA 70803 USA
来源
NEOPLASIA | 2005年 / 7卷 / 03期
关键词
malignant melanoma; heparanase; heparan sulfate; invasion and metastasis; anti-sense gene delivery;
D O I
10.1593/neo.04493
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer metastasis is a frequent manifestation of malignant melanoma progression. Successful invasion into distant organs by tumor cells must include attachment to microvessel endothelial cells, and degradation of basement membranes and extracellular matrix (ECM). Heparan sulfate proteoglycans (HSPG) are essential and ubiquitous macromolecules associated with the cell surface and ECM of a wide range of cells and tissues. Heparanase (HPSE-1) is an ECM degradative enzyme, which degrades the heparan sulfate (HS) chains of HSPG at specific intrachain sites. To investigate effects of changes in heparanase gene expression in metastatic melanoma cells, we constructed adenoviral vectors containing the full-length human HPSE-1 cDNA in both sense (Ad-S/hep) and antisense orientations (Ad-AS/hep). We found increased HPSE-1 expression and activity in melanoma cell lines following Ad-S/hep infection by Western blot analyses and specific HPSE-1 activity assay. Conversely, HPSE-1 content was significantly inhibited following infection with Ad-AS/Hep. Importantly, HPSE-1 modulation by these adenoviral constructs correlated with invasive cellular properties in vitro and in vivo. Our results suggest that HPSE-1 not only contributes to the invasive phenotype of melanoma cells, but also that the Ad-AS/hep-mediated inhibition of its enzymatic activity can be efficacious in the prevention and treatment of melanoma metastasis.
引用
收藏
页码:253 / 262
页数:10
相关论文
共 49 条
[1]   Functions of cell surface heparan sulfate proteoglycans [J].
Bernfield, M ;
Götte, M ;
Park, PW ;
Reizes, O ;
Fitzgerald, ML ;
Lincecum, J ;
Zako, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :729-777
[2]   Antitumour activity of suramin analogues in human tumour cell lines and primary cultures of tumour cells from patients [J].
Dhar, S ;
Gullbo, J ;
Csoka, K ;
Eriksson, E ;
Nilsson, K ;
Nickel, P ;
Larsson, R ;
Nygren, P .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (06) :803-809
[3]   Elevated levels of shed syndecan-1 correlate with tumour mass and decreased matrix metalloproteinase-9 activity in the serum of patients with multiple myeloma [J].
Dhodapkar, MV ;
Kelly, T ;
Theus, A ;
Athota, AB ;
Barlogie, B ;
Sanderson, RD .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (02) :368-371
[4]   Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis [J].
Edovitsky, E ;
Elkin, M ;
Zcharia, E ;
Peretz, T ;
Vlodavsky, I .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (16) :1219-1230
[5]  
Engbring JA, 2002, CANCER RES, V62, P3549
[6]   ENZYMATIC DEGRADATION OF GLYCOSAMINOGLYCANS [J].
ERNST, S ;
LANGER, R ;
COONEY, CL ;
SASISEKHARAN, R .
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 30 (05) :387-444
[7]   Expression in Escherichia coli, purification and characterization of heparinase I from Flavobacterium heparinum [J].
Ernst, S ;
Venkataraman, G ;
Winkler, S ;
Godavarti, R ;
Langer, R ;
Cooney, CL ;
Sasisekharan, R .
BIOCHEMICAL JOURNAL, 1996, 315 :589-597
[8]   Processing of the human heparanase precursor and evidence that the active enzyme is a heterodimer [J].
Fairbanks, MB ;
Mildner, AM ;
Leone, JW ;
Cavey, GS ;
Mathews, WR ;
Drong, RF ;
Slightom, JL ;
Bienkowski, MJ ;
Smith, CW ;
Bannow, CA ;
Heinrikson, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (42) :29587-29590
[9]   Angiogenesis-dependent diseases [J].
Folkman, J .
SEMINARS IN ONCOLOGY, 2001, 28 (06) :536-542
[10]   Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis [J].
Hulett, MD ;
Freeman, C ;
Hamdorf, BJ ;
Baker, RT ;
Harris, MJ ;
Parish, CR .
NATURE MEDICINE, 1999, 5 (07) :803-809